Magyari M - Search Results

1

Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.

Boesen MS, Jensen PEH, Magyari M, Born AP, Uldall PV, Blinkenberg M, Sellebjerg F. Boesen MS, et al. Among authors: magyari m. Mult Scler Relat Disord. 2018 Aug;24:175-183. doi: 10.1016/j.msard.2018.05.017. Epub 2018 Jun 11. Mult Scler Relat Disord. 2018. PMID: 30055504

2

[Iodine deficiency in cardiovascular diseases].

Molnár I, Magyari M, Stief L. Molnár I, et al. Among authors: magyari m. Orv Hetil. 1998 Aug 30;139(35):2071-3. Orv Hetil. 1998. PMID: 9755626 Hungarian.

3

Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study).

Magyari M, Bach Søndergaard H, Sellebjerg F, Soelberg Sørensen P. Magyari M, et al. Mult Scler Relat Disord. 2013 Apr;2(2):141-6. doi: 10.1016/j.msard.2012.10.001. Epub 2012 Dec 11. Mult Scler Relat Disord. 2013. PMID: 25877635

4

Physical and social environment and the risk of multiple sclerosis.

Magyari M, Koch-Henriksen N, Pfleger CC, Sørensen PS. Magyari M, et al. Mult Scler Relat Disord. 2014 Sep;3(5):600-6. doi: 10.1016/j.msard.2014.07.002. Epub 2014 Jul 21. Mult Scler Relat Disord. 2014. PMID: 26265272

5

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry.

Dreyer L, Magyari M, Laursen B, Cordtz R, Sellebjerg F, Locht H. Dreyer L, et al. Among authors: magyari m. Ann Rheum Dis. 2016 Apr;75(4):785-6. doi: 10.1136/annrheumdis-2015-208490. Epub 2015 Dec 23. Ann Rheum Dis. 2016. PMID: 26698850 No abstract available.

6

A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.

Koch-Henriksen N, Magyari M, Sellebjerg F, Soelberg Sørensen P. Koch-Henriksen N, et al. Among authors: magyari m. Mult Scler. 2017 Feb;23(2):234-241. doi: 10.1177/1352458516643393. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27055806

7

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Schreiber K, Magyari M, Sellebjerg F, Iversen P, Garde E, Madsen CG, Börnsen L, Romme Christensen J, Ratzer R, Siebner HR, Laursen B, Soelberg Sorensen P. Schreiber K, et al. Among authors: magyari m. Mult Scler. 2017 Apr;23(5):675-685. doi: 10.1177/1352458516661048. Epub 2016 Aug 5. Mult Scler. 2017. PMID: 27481206 Clinical Trial.

8

Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population.

Gustavsen S, Søndergaard HB, Oturai DB, Laursen B, Laursen JH, Magyari M, Ullum H, Larsen MH, Sellebjerg F, Oturai AB. Gustavsen S, et al. Among authors: magyari m. Mult Scler Relat Disord. 2016 Sep;9:104-9. doi: 10.1016/j.msard.2016.06.010. Epub 2016 Jun 27. Mult Scler Relat Disord. 2016. PMID: 27645354

9

Early safety and efficacy of fingolimod treatment in Denmark.

Voldsgaard A, Koch-Henriksen N, Magyari M, Sellebjerg F, Sørensen PS, Oturai AB. Voldsgaard A, et al. Among authors: magyari m. Acta Neurol Scand. 2017 Jan;135(1):129-133. doi: 10.1111/ane.12573. Epub 2016 Mar 8. Acta Neurol Scand. 2017. PMID: 27910101

10

Inverse comorbidity in multiple sclerosis: Findings in a complete nationwide cohort.

Thormann A, Koch-Henriksen N, Laursen B, Sørensen PS, Magyari M. Thormann A, et al. Among authors: magyari m. Mult Scler Relat Disord. 2016 Nov;10:181-186. doi: 10.1016/j.msard.2016.10.008. Epub 2016 Oct 29. Mult Scler Relat Disord. 2016. PMID: 27919487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page